Genital tumors among men with psoriasis exposed to psoralens and ultraviolet A radiation (PUVA) and ultraviolet B radiation. The Photochemotherapy Follow-up Study
Squamous-cell cancer occurs only rarely on the male genitalia. In a 12.3-year prospective study of 892 men in a cohort of patients with psoriasis who had been treated with oral methoxsalen (8-methoxypsoralen) and ultraviolet A photochemotherapy (PUVA), we identified 14 patients (1.6 percent) with 30 genital neoplasms. The standard morbidity ratio (which was used as a measure of the risk of a genital neoplasm) comparing morbidity among patients treated with PUVA with that expected on the basis of population incidence data was 95.7 (95 percent confidence interval, 43.8 to 181.8) for invasive squamous-cell carcinoma of the penis and scrotum, and 58.8 (26.9 to 111.7) for invasive and in situ penile tumors. In patients exposed to high levels of PUVA, the incidence of invasive squamous-cell carcinoma was 286 times that in the general population and 16.3 times that in patients exposed to low levels (P less than 0.001 for both comparisons). After controlling for the level of exposure to PUVA, we found that patients exposed to high levels of ultraviolet B radiation had a risk of genital tumors 4.6 times higher than that in other patients (95 percent confidence interval, 1.4 to 15.1). The strongly dose-dependent increase in the risk of genital tumors associated with exposure to PUVA and ultraviolet B radiation that we observed makes it prudent for men to use genital protection whenever they are exposed to PUVA or other forms of ultraviolet radiation for therapeutic, recreational, or cosmetic reasons.
Source Information
Department of Dermatology, Beth Israel Hospital, Boston, MA 02215.
This article has been cited by other articles:
Stern, R. S.
(2007). Psoralen and Ultraviolet A Light Therapy for Psoriasis. NEJM
357: 682-690
[Full Text]
Alexiades-Armenakas, M. R., Bernstein, L. J., Friedman, P. M., Geronemus, R. G.
(2004). The Safety and Efficacy of the 308-nm Excimer Laser for Pigment Correction of Hypopigmented Scars and Striae Alba. Arch Dermatol
140: 955-960
[Abstract][Full Text]
Pasker-de Jong, P. C. M., Wielink, G., van der Valk, P. G. M., van der Wilt, G.-J.
(1999). Treatment With UV-B for Psoriasis and Nonmelanoma Skin Cancer: A Systematic Review of the Literature. Arch Dermatol
135: 834-840
[Abstract][Full Text]
Morison, W. L., Baughman, R. D., Day, R. M., Forbes, P. D., Hoenigsmann, H., Krueger, G. G., Lebwohl, M., Lew, R., Naldi, L., Parrish, J. A., Piepkorn, M., Stern, R. S., Weinstein, G. D., Whitmore, S. E.
(1998). Consensus Workshop on the Toxic Effects of Long-term PUVA Therapy. Arch Dermatol
134: 595-598
[Abstract][Full Text]
Stern, R. S., Nichols, K. T., Vakeva, L. H., The PUVA Follow-up Study,
(1997). Malignant Melanoma in Patients Treated for Psoriasis with Methoxsalen (Psoralen) and Ultraviolet A Radiation (PUVA). NEJM
336: 1041-1045
[Abstract][Full Text]
Baughman, R. D.
(1996). A 61-Year-Old Man With Psoriasis. JAMA
276: 1421-1428
[Abstract]
Greaves, M. W., Weinstein, G. D.
(1995). Treatment of Psoriasis. NEJM
332: 581-589
[Full Text]
Lindelof, B., Sigurgeirsson, B., Tegner, E., Larko, O., Berne, B.
(1992). Comparison of the Carcinogenic Potential of Trioxsalen Bath PUVA and Oral Methoxsalen PUVA: A Preliminary Report. Arch Dermatol
128: 1341-1344
[Abstract]
Stern, R. S., Lange, R.
(1991). Outcomes of Pregnancies Among Women and Partners of Men With a History of Exposure to Methoxsalen Photochemotherapy (PUVA) for the Treatment of Psoriasis. Arch Dermatol
127: 347-350
[Abstract]
Potter, G.K., Ward, K. A.
(1990). Book Reviews : Mechanisms Involved in Photobiologic Reactions of the Skin. The Journal of the Royal Society for the Promotion of Health
110: 228-228
(1990). PUVA TREATMENT FOR PSORIASIS CAUSES GENITAL TUMORS IN MEN. JWatch General
1990: 1-1
[Full Text]
